隐匿性 GCA:巨细胞动脉炎的罕见变种

IF 3 3区 医学 Q1 OPHTHALMOLOGY Acta Ophthalmologica Pub Date : 2024-06-21 DOI:10.1111/aos.16731
Lorenzo Huang, Fariba Fallahzadeh, Gauti Jóhannesson
{"title":"隐匿性 GCA:巨细胞动脉炎的罕见变种","authors":"Lorenzo Huang,&nbsp;Fariba Fallahzadeh,&nbsp;Gauti Jóhannesson","doi":"10.1111/aos.16731","DOIUrl":null,"url":null,"abstract":"<p>An 82-year-old Scandinavian woman with hypertension and diabetes mellitus type 2 experienced 1–2 seconds of blurred vision alternating between right and left eye, never together. There were no associated symptoms such as fatigue, headache or jaw claudication, no sign of temporary visual field loss or ‘dark curtain’. The visual acuity was 0.6/0.6 Snellen explained by moderate cataract with pseudo exfoliation, normal bilateral intraocular pressure and fundoscopy that revealed optic disks with normal size and features bilaterally. There was bilateral calcification-like deposit on the central cornea, initially thought to explain her brief visual disturbances. She was discharged with tear substitutes and instructed to return in case of worsening of symptoms.</p><p>The patient contacted the clinic a week later, reporting altitudinal lower visual field loss in her left eye that worsened to almost total visual loss (Figure 1a). Upon examination, the patient confirmed again absence of the above-mentioned symptoms (no temporal/generalized headache, jaw claudication, scalp pain while combing hair or polymyalgia rheumatica symptoms), no signs of confusion, tiredness, neurological abnormalities, pain in the eye, weight loss or fever. She was a non-smoker and did not have sleep apnoea. Her left eye had 0.4 Snellen visual acuity, optic disc swelling (Figure 1b), no signs of retinal ischemia and a positive left relative afferent pupillary defect (RAPD). C-reactive protein (CRP) and sedimentation rate (SR) were normal, orbital magnetic resonance imaging (MRI) showed no optic abnormalities that could explain the visual field loss. Despite the lack of giant cell arteritis (GCA) symptoms, a rheumatologist was consulted and according to his assessment, an ultrasound (US) evaluation was not deemed necessary. The patient was diagnosed with left sided non-arteritic anterior ischemic optic neuropathy (NA-AION) with a referral to the general practitioner for further cardiovascular risk evaluation.</p><p>The patient was followed up with periodical visual field and visual acuity assessment without reporting new vision deterioration. An additional neck-brain angiography showed no significant findings such as endangering stenosis and the patient was treated with 40 mg oral prednisolone for 2 weeks. Over 2 months of follow up, the left visual field improved from visual field index (VFI) 8–24% and the left optic disc swelling regressed to optic atrophy.</p><p>The patient contacted the eye clinic 3 weeks before the planned final-check due to sudden upper altitudinal hemianopia in her right eye and worsening of her remaining left visual field (Figure 2a). Like before, the patient was totally asymptomatic, no symptoms as listed above besides the sudden right visual field loss. The examinations revealed worsening of visual acuity (0.4/0.3), a fresh right optic disc swelling (Figure 2b) and optic disc atrophy on the left (Figure 2c). Due to bilateral worsening with neither GCA symptoms nor inflammatory markers elevation, the patient was referred to the emergency department for suspected stroke or new onset of Space Occupying Lesion (SOL) and bilateral NA-AION as differential diagnosis.</p><p>After a normal computer tomography without new vascular pathologies the emergency doctor, in consultation with a neurologist, initiated a temporary double anticoagulant therapy and the patient was booked for a new evaluation at the neurology department.</p><p>Although the likelihood of Arteritic AION (A-AION) was deemed highly unlikely, a new rheumatology consultation for a temporal artery ultrasound assessment was suggested. The sonography showed a characteristic halo-sign in multiple branches of the temporal artery bilaterally (Figure 3a–c) and occasionally thickened wall on the distal part of the left axillary artery (Figure 3d), leading to the diagnosis of GCA. However, the patient did not want to perform a Temporal Artery Biopsy (TAB) due to anxiety and according to the local guidelines, a positive US halo-sign is sufficient to confirm an active GCA. Intravenous methylprednisolone was initiated followed by slow tapered oral prednisolone.</p><p>The patient visual status did not deteriorate following aggressive corticosteroid treatment according to her latest visual field test (Figure 4).</p><p>Giant Cell Arteritis (GCA) is a chronic granulomatous inflammation of medium-to-large arteries that affects commonly the carotid artery and its branches causing classical symptoms such as fever, temporal tenderness, jaw claudication, polymyalgia rheumatica (PMR) complaints and, if untreated, visual field loss (Zaragoza et al., <span>2015</span>).</p><p>According to a previous meta-analysis, the incidence of GCA is 10 cases per 100 000 people above the 50 years of age, highest in Scandinavia 21.6 [18.9, 24.2], followed by North and South America 10.9, Europe 7.3 and Oceania 7.9 (Li et al., <span>2021</span>).</p><p>Focal GCA symptoms develop because the vascular inflammation involves areas that are supplied by affected peripheral vessels (therefore temporal headache, jaw claudication and rare cases of tongue necrosis). However, the GCA picture is very variable, and therefore, the patients do not always present with all these classic symptoms.</p><p>Based on this clinical case development and findings, the above-mentioned patient was diagnosed with Occult GCA, an ocular variant of GCA with an incidence of 14.3% (Issa et al., <span>2022</span>) and up to 21.2% characterized by an absence of systemic symptoms and signs commonly associated with GCA (Hayreh et al., <span>1998</span>). The patient showed neither elevation of inflammatory markers nor systemic symptoms besides AION and visual field defects bilaterally, a very rare exception.</p><p>Bilateral NA-AION could be a possible differential diagnosis but the diagnosis of A-AION is supported by the ultrasound examination which was conducted by two distinct professionals. The examination revealed halo-signs across multiple arterial branches bilaterally. The halo-signs were seen on both the right and left a. temporalis with occasional presence of thickened wall of the left distal a. axillaris. Atherosclerosis was ruled out and thus, these findings confirmed the suspicion of GCA. Furthermore, the cessation of bilateral visual field deterioration coincided with the commencement of aggressive corticosteroid therapy, which is a therapy that yields no significant benefits in NA-AION (Hayreh &amp; Zimmerman, <span>2008</span>).</p><p>Since Northern European regions have a higher risk for GCA development, it is reasonable that Scandinavian physicians should be familiarized with this rare GCA variant, maintain a low threshold for GCA testing in the relevant demographic group and leveraging cost-effective ultrasound examinations can be beneficial in early detection and management.</p><p>In case of bilateral sequential AION in patients above the age of 50 it is advised to implement temporal artery sonographic examination to exclude the possibility of an Occult GCA. However, it is crucial to differentiate the US halo-sign between the arterial intimal thickening (characteristic of GCA) and atherosclerosis.</p><p>According to the 2023 EULAR recommendation, US of temporal and axillary arteries should be considered as the first-line imaging modality to investigate suspected GCA (Dejaco et al., <span>2023</span>). In cases of sequential bilateral AION, if uncertainty remains despite ultrasound evaluation, other diagnostic imaging are suggested and further differential diagnosis should be considered such as optic neuritis, SOL, Foster-Kennedy Syndrome (FSK) by a skull base tumour and pseudo-FSK, IIH, sarcoidosis and hypertensive crisis. Temporal Artery Biopsy (TAB) is the gold standard for GCA diagnosis; however, it is invasive with inherent risks as well as unreliable due to tissue sampling (Crain et al., <span>2021</span>).</p><p>This case highlights also ultrasound's pivotal role in modern GCA detection, enhancing diagnostic accuracy in a disease that shows a very diverse clinical presentation. This cost-effective and quick investigation can be vision saving in asymptomatic patients or geriatric populations that are too old to show specific GCA symptoms, group-at-risk that is ever-increasing in the modern western society.</p>","PeriodicalId":6915,"journal":{"name":"Acta Ophthalmologica","volume":"102 8","pages":"968-973"},"PeriodicalIF":3.0000,"publicationDate":"2024-06-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/aos.16731","citationCount":"0","resultStr":"{\"title\":\"Occult GCA: A rare variant of Giant Cell Arteritis\",\"authors\":\"Lorenzo Huang,&nbsp;Fariba Fallahzadeh,&nbsp;Gauti Jóhannesson\",\"doi\":\"10.1111/aos.16731\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>An 82-year-old Scandinavian woman with hypertension and diabetes mellitus type 2 experienced 1–2 seconds of blurred vision alternating between right and left eye, never together. There were no associated symptoms such as fatigue, headache or jaw claudication, no sign of temporary visual field loss or ‘dark curtain’. The visual acuity was 0.6/0.6 Snellen explained by moderate cataract with pseudo exfoliation, normal bilateral intraocular pressure and fundoscopy that revealed optic disks with normal size and features bilaterally. There was bilateral calcification-like deposit on the central cornea, initially thought to explain her brief visual disturbances. She was discharged with tear substitutes and instructed to return in case of worsening of symptoms.</p><p>The patient contacted the clinic a week later, reporting altitudinal lower visual field loss in her left eye that worsened to almost total visual loss (Figure 1a). Upon examination, the patient confirmed again absence of the above-mentioned symptoms (no temporal/generalized headache, jaw claudication, scalp pain while combing hair or polymyalgia rheumatica symptoms), no signs of confusion, tiredness, neurological abnormalities, pain in the eye, weight loss or fever. She was a non-smoker and did not have sleep apnoea. Her left eye had 0.4 Snellen visual acuity, optic disc swelling (Figure 1b), no signs of retinal ischemia and a positive left relative afferent pupillary defect (RAPD). C-reactive protein (CRP) and sedimentation rate (SR) were normal, orbital magnetic resonance imaging (MRI) showed no optic abnormalities that could explain the visual field loss. Despite the lack of giant cell arteritis (GCA) symptoms, a rheumatologist was consulted and according to his assessment, an ultrasound (US) evaluation was not deemed necessary. The patient was diagnosed with left sided non-arteritic anterior ischemic optic neuropathy (NA-AION) with a referral to the general practitioner for further cardiovascular risk evaluation.</p><p>The patient was followed up with periodical visual field and visual acuity assessment without reporting new vision deterioration. An additional neck-brain angiography showed no significant findings such as endangering stenosis and the patient was treated with 40 mg oral prednisolone for 2 weeks. Over 2 months of follow up, the left visual field improved from visual field index (VFI) 8–24% and the left optic disc swelling regressed to optic atrophy.</p><p>The patient contacted the eye clinic 3 weeks before the planned final-check due to sudden upper altitudinal hemianopia in her right eye and worsening of her remaining left visual field (Figure 2a). Like before, the patient was totally asymptomatic, no symptoms as listed above besides the sudden right visual field loss. The examinations revealed worsening of visual acuity (0.4/0.3), a fresh right optic disc swelling (Figure 2b) and optic disc atrophy on the left (Figure 2c). Due to bilateral worsening with neither GCA symptoms nor inflammatory markers elevation, the patient was referred to the emergency department for suspected stroke or new onset of Space Occupying Lesion (SOL) and bilateral NA-AION as differential diagnosis.</p><p>After a normal computer tomography without new vascular pathologies the emergency doctor, in consultation with a neurologist, initiated a temporary double anticoagulant therapy and the patient was booked for a new evaluation at the neurology department.</p><p>Although the likelihood of Arteritic AION (A-AION) was deemed highly unlikely, a new rheumatology consultation for a temporal artery ultrasound assessment was suggested. The sonography showed a characteristic halo-sign in multiple branches of the temporal artery bilaterally (Figure 3a–c) and occasionally thickened wall on the distal part of the left axillary artery (Figure 3d), leading to the diagnosis of GCA. However, the patient did not want to perform a Temporal Artery Biopsy (TAB) due to anxiety and according to the local guidelines, a positive US halo-sign is sufficient to confirm an active GCA. Intravenous methylprednisolone was initiated followed by slow tapered oral prednisolone.</p><p>The patient visual status did not deteriorate following aggressive corticosteroid treatment according to her latest visual field test (Figure 4).</p><p>Giant Cell Arteritis (GCA) is a chronic granulomatous inflammation of medium-to-large arteries that affects commonly the carotid artery and its branches causing classical symptoms such as fever, temporal tenderness, jaw claudication, polymyalgia rheumatica (PMR) complaints and, if untreated, visual field loss (Zaragoza et al., <span>2015</span>).</p><p>According to a previous meta-analysis, the incidence of GCA is 10 cases per 100 000 people above the 50 years of age, highest in Scandinavia 21.6 [18.9, 24.2], followed by North and South America 10.9, Europe 7.3 and Oceania 7.9 (Li et al., <span>2021</span>).</p><p>Focal GCA symptoms develop because the vascular inflammation involves areas that are supplied by affected peripheral vessels (therefore temporal headache, jaw claudication and rare cases of tongue necrosis). However, the GCA picture is very variable, and therefore, the patients do not always present with all these classic symptoms.</p><p>Based on this clinical case development and findings, the above-mentioned patient was diagnosed with Occult GCA, an ocular variant of GCA with an incidence of 14.3% (Issa et al., <span>2022</span>) and up to 21.2% characterized by an absence of systemic symptoms and signs commonly associated with GCA (Hayreh et al., <span>1998</span>). The patient showed neither elevation of inflammatory markers nor systemic symptoms besides AION and visual field defects bilaterally, a very rare exception.</p><p>Bilateral NA-AION could be a possible differential diagnosis but the diagnosis of A-AION is supported by the ultrasound examination which was conducted by two distinct professionals. The examination revealed halo-signs across multiple arterial branches bilaterally. The halo-signs were seen on both the right and left a. temporalis with occasional presence of thickened wall of the left distal a. axillaris. Atherosclerosis was ruled out and thus, these findings confirmed the suspicion of GCA. Furthermore, the cessation of bilateral visual field deterioration coincided with the commencement of aggressive corticosteroid therapy, which is a therapy that yields no significant benefits in NA-AION (Hayreh &amp; Zimmerman, <span>2008</span>).</p><p>Since Northern European regions have a higher risk for GCA development, it is reasonable that Scandinavian physicians should be familiarized with this rare GCA variant, maintain a low threshold for GCA testing in the relevant demographic group and leveraging cost-effective ultrasound examinations can be beneficial in early detection and management.</p><p>In case of bilateral sequential AION in patients above the age of 50 it is advised to implement temporal artery sonographic examination to exclude the possibility of an Occult GCA. However, it is crucial to differentiate the US halo-sign between the arterial intimal thickening (characteristic of GCA) and atherosclerosis.</p><p>According to the 2023 EULAR recommendation, US of temporal and axillary arteries should be considered as the first-line imaging modality to investigate suspected GCA (Dejaco et al., <span>2023</span>). In cases of sequential bilateral AION, if uncertainty remains despite ultrasound evaluation, other diagnostic imaging are suggested and further differential diagnosis should be considered such as optic neuritis, SOL, Foster-Kennedy Syndrome (FSK) by a skull base tumour and pseudo-FSK, IIH, sarcoidosis and hypertensive crisis. Temporal Artery Biopsy (TAB) is the gold standard for GCA diagnosis; however, it is invasive with inherent risks as well as unreliable due to tissue sampling (Crain et al., <span>2021</span>).</p><p>This case highlights also ultrasound's pivotal role in modern GCA detection, enhancing diagnostic accuracy in a disease that shows a very diverse clinical presentation. This cost-effective and quick investigation can be vision saving in asymptomatic patients or geriatric populations that are too old to show specific GCA symptoms, group-at-risk that is ever-increasing in the modern western society.</p>\",\"PeriodicalId\":6915,\"journal\":{\"name\":\"Acta Ophthalmologica\",\"volume\":\"102 8\",\"pages\":\"968-973\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-06-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/aos.16731\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Ophthalmologica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/aos.16731\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Ophthalmologica","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/aos.16731","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

1 病例报告 一位 82 岁的斯堪的纳维亚女性患者患有高血压和 2 型糖尿病,她在左右眼交替出现 1-2 秒钟的视力模糊,从未同时出现过。没有疲劳、头痛或下颌挛缩等相关症状,也没有暂时性视野缺损或 "黑幕 "的迹象。视力为 0.6/0.6 Snellen,解释为中度白内障伴假性角膜剥脱,双侧眼压正常,眼底镜检查显示视盘大小和特征正常。中央角膜上有双侧钙化样沉积物,最初被认为是她短暂视力障碍的原因。一周后,患者联系诊所,称其左眼下部视野缺损,并恶化到几乎完全丧失视力(图 1a)。经检查,患者再次确认没有上述症状(没有颞部/全身性头痛、下颌跛行、梳头时头皮疼痛或多发性风湿痛症状),也没有精神错乱、疲倦、神经系统异常、眼睛疼痛、体重减轻或发烧的迹象。她不吸烟,也没有睡眠呼吸暂停症状。她的左眼斯奈伦视力为 0.4,视盘肿胀(图 1b),没有视网膜缺血的迹象,左侧相对传入瞳孔缺损(RAPD)呈阳性。C反应蛋白(CRP)和血沉(SR)正常,眼眶磁共振成像(MRI)显示没有可以解释视野缺失的视神经异常。尽管患者没有巨细胞动脉炎(GCA)症状,但还是咨询了风湿病专家,根据他的评估,认为没有必要进行超声波(US)评估。患者被诊断为左侧非动脉炎性前部缺血性视神经病变(NA-AION),并被转诊至全科医生处进行进一步的心血管风险评估。(b) AION 引起的左侧视盘肿胀。患者接受了定期视野和视力评估,但未报告新的视力恶化。患者接受了为期两周的 40 毫克口服泼尼松龙治疗。在两个多月的随访中,患者的左视野从视野指数(VFI)8%-24%有所改善,左侧视盘肿胀消退为视神经萎缩。患者在计划的最后一次检查前三周联系了眼科诊所,原因是她的右眼突然出现上半部偏盲,剩余的左视野也在恶化(图 2a)。与之前一样,患者完全没有症状,除了右眼视野突然缺失外,没有上述任何症状。检查发现视力恶化(0.4/0.3),右侧视盘肿胀(图 2b),左侧视盘萎缩(图 2c)。由于双侧病情恶化,既无 GCA 症状,也无炎症标志物升高,患者被转诊至急诊科,以疑似中风或新发占位性病变(SOL)和双侧 NA-AION 作为鉴别诊断。(b) AION 引起的右侧视盘肿胀。(计算机断层扫描结果正常,未发现新的血管病变,急诊医生与神经科医生会诊后,为患者启动了临时双联抗凝疗法,并预约患者到神经科接受新的评估。尽管动脉性缺血性视神经病变(A-AION)被认为可能性极小,但还是建议患者到风湿病科接受新的颞动脉超声波评估。超声波检查显示双侧颞动脉的多个分支出现特征性光晕征(图 3a-c),左侧腋动脉远端偶尔出现管壁增厚(图 3d),因此诊断为 GCA。然而,患者因焦虑而不愿进行颞动脉活检(TAB),而根据当地指南,美国光晕征阳性足以确诊为活动性 GCA。开始静脉注射甲基强的松龙,随后缓慢减量口服强的松龙。图 3在图形浏览器中打开PowerPoint(a)巨细胞动脉炎(GCA)晕征--左侧颞动脉内膜增厚(箭头所示)。(b) GCA 光晕征--右侧 a. temporalis 额支内膜增厚(箭头所示)。(c) GCA 晕轮征 - 右侧颞动脉内膜增厚,手绘内膜增厚区域(黄色)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Occult GCA: A rare variant of Giant Cell Arteritis

An 82-year-old Scandinavian woman with hypertension and diabetes mellitus type 2 experienced 1–2 seconds of blurred vision alternating between right and left eye, never together. There were no associated symptoms such as fatigue, headache or jaw claudication, no sign of temporary visual field loss or ‘dark curtain’. The visual acuity was 0.6/0.6 Snellen explained by moderate cataract with pseudo exfoliation, normal bilateral intraocular pressure and fundoscopy that revealed optic disks with normal size and features bilaterally. There was bilateral calcification-like deposit on the central cornea, initially thought to explain her brief visual disturbances. She was discharged with tear substitutes and instructed to return in case of worsening of symptoms.

The patient contacted the clinic a week later, reporting altitudinal lower visual field loss in her left eye that worsened to almost total visual loss (Figure 1a). Upon examination, the patient confirmed again absence of the above-mentioned symptoms (no temporal/generalized headache, jaw claudication, scalp pain while combing hair or polymyalgia rheumatica symptoms), no signs of confusion, tiredness, neurological abnormalities, pain in the eye, weight loss or fever. She was a non-smoker and did not have sleep apnoea. Her left eye had 0.4 Snellen visual acuity, optic disc swelling (Figure 1b), no signs of retinal ischemia and a positive left relative afferent pupillary defect (RAPD). C-reactive protein (CRP) and sedimentation rate (SR) were normal, orbital magnetic resonance imaging (MRI) showed no optic abnormalities that could explain the visual field loss. Despite the lack of giant cell arteritis (GCA) symptoms, a rheumatologist was consulted and according to his assessment, an ultrasound (US) evaluation was not deemed necessary. The patient was diagnosed with left sided non-arteritic anterior ischemic optic neuropathy (NA-AION) with a referral to the general practitioner for further cardiovascular risk evaluation.

The patient was followed up with periodical visual field and visual acuity assessment without reporting new vision deterioration. An additional neck-brain angiography showed no significant findings such as endangering stenosis and the patient was treated with 40 mg oral prednisolone for 2 weeks. Over 2 months of follow up, the left visual field improved from visual field index (VFI) 8–24% and the left optic disc swelling regressed to optic atrophy.

The patient contacted the eye clinic 3 weeks before the planned final-check due to sudden upper altitudinal hemianopia in her right eye and worsening of her remaining left visual field (Figure 2a). Like before, the patient was totally asymptomatic, no symptoms as listed above besides the sudden right visual field loss. The examinations revealed worsening of visual acuity (0.4/0.3), a fresh right optic disc swelling (Figure 2b) and optic disc atrophy on the left (Figure 2c). Due to bilateral worsening with neither GCA symptoms nor inflammatory markers elevation, the patient was referred to the emergency department for suspected stroke or new onset of Space Occupying Lesion (SOL) and bilateral NA-AION as differential diagnosis.

After a normal computer tomography without new vascular pathologies the emergency doctor, in consultation with a neurologist, initiated a temporary double anticoagulant therapy and the patient was booked for a new evaluation at the neurology department.

Although the likelihood of Arteritic AION (A-AION) was deemed highly unlikely, a new rheumatology consultation for a temporal artery ultrasound assessment was suggested. The sonography showed a characteristic halo-sign in multiple branches of the temporal artery bilaterally (Figure 3a–c) and occasionally thickened wall on the distal part of the left axillary artery (Figure 3d), leading to the diagnosis of GCA. However, the patient did not want to perform a Temporal Artery Biopsy (TAB) due to anxiety and according to the local guidelines, a positive US halo-sign is sufficient to confirm an active GCA. Intravenous methylprednisolone was initiated followed by slow tapered oral prednisolone.

The patient visual status did not deteriorate following aggressive corticosteroid treatment according to her latest visual field test (Figure 4).

Giant Cell Arteritis (GCA) is a chronic granulomatous inflammation of medium-to-large arteries that affects commonly the carotid artery and its branches causing classical symptoms such as fever, temporal tenderness, jaw claudication, polymyalgia rheumatica (PMR) complaints and, if untreated, visual field loss (Zaragoza et al., 2015).

According to a previous meta-analysis, the incidence of GCA is 10 cases per 100 000 people above the 50 years of age, highest in Scandinavia 21.6 [18.9, 24.2], followed by North and South America 10.9, Europe 7.3 and Oceania 7.9 (Li et al., 2021).

Focal GCA symptoms develop because the vascular inflammation involves areas that are supplied by affected peripheral vessels (therefore temporal headache, jaw claudication and rare cases of tongue necrosis). However, the GCA picture is very variable, and therefore, the patients do not always present with all these classic symptoms.

Based on this clinical case development and findings, the above-mentioned patient was diagnosed with Occult GCA, an ocular variant of GCA with an incidence of 14.3% (Issa et al., 2022) and up to 21.2% characterized by an absence of systemic symptoms and signs commonly associated with GCA (Hayreh et al., 1998). The patient showed neither elevation of inflammatory markers nor systemic symptoms besides AION and visual field defects bilaterally, a very rare exception.

Bilateral NA-AION could be a possible differential diagnosis but the diagnosis of A-AION is supported by the ultrasound examination which was conducted by two distinct professionals. The examination revealed halo-signs across multiple arterial branches bilaterally. The halo-signs were seen on both the right and left a. temporalis with occasional presence of thickened wall of the left distal a. axillaris. Atherosclerosis was ruled out and thus, these findings confirmed the suspicion of GCA. Furthermore, the cessation of bilateral visual field deterioration coincided with the commencement of aggressive corticosteroid therapy, which is a therapy that yields no significant benefits in NA-AION (Hayreh & Zimmerman, 2008).

Since Northern European regions have a higher risk for GCA development, it is reasonable that Scandinavian physicians should be familiarized with this rare GCA variant, maintain a low threshold for GCA testing in the relevant demographic group and leveraging cost-effective ultrasound examinations can be beneficial in early detection and management.

In case of bilateral sequential AION in patients above the age of 50 it is advised to implement temporal artery sonographic examination to exclude the possibility of an Occult GCA. However, it is crucial to differentiate the US halo-sign between the arterial intimal thickening (characteristic of GCA) and atherosclerosis.

According to the 2023 EULAR recommendation, US of temporal and axillary arteries should be considered as the first-line imaging modality to investigate suspected GCA (Dejaco et al., 2023). In cases of sequential bilateral AION, if uncertainty remains despite ultrasound evaluation, other diagnostic imaging are suggested and further differential diagnosis should be considered such as optic neuritis, SOL, Foster-Kennedy Syndrome (FSK) by a skull base tumour and pseudo-FSK, IIH, sarcoidosis and hypertensive crisis. Temporal Artery Biopsy (TAB) is the gold standard for GCA diagnosis; however, it is invasive with inherent risks as well as unreliable due to tissue sampling (Crain et al., 2021).

This case highlights also ultrasound's pivotal role in modern GCA detection, enhancing diagnostic accuracy in a disease that shows a very diverse clinical presentation. This cost-effective and quick investigation can be vision saving in asymptomatic patients or geriatric populations that are too old to show specific GCA symptoms, group-at-risk that is ever-increasing in the modern western society.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Acta Ophthalmologica
Acta Ophthalmologica 医学-眼科学
CiteScore
7.60
自引率
5.90%
发文量
433
审稿时长
6 months
期刊介绍: Acta Ophthalmologica is published on behalf of the Acta Ophthalmologica Scandinavica Foundation and is the official scientific publication of the following societies: The Danish Ophthalmological Society, The Finnish Ophthalmological Society, The Icelandic Ophthalmological Society, The Norwegian Ophthalmological Society and The Swedish Ophthalmological Society, and also the European Association for Vision and Eye Research (EVER). Acta Ophthalmologica publishes clinical and experimental original articles, reviews, editorials, educational photo essays (Diagnosis and Therapy in Ophthalmology), case reports and case series, letters to the editor and doctoral theses.
期刊最新文献
Efficacy of intravitreal faricimab therapy for polypoidal choroidal vasculopathy: A systematic review and meta-analysis. The ever ongoing cosmetic quest to change eye colour. Slowing myopia progression with cylindrical annular refractive elements (CARE) spectacle lenses-Year 1 results from a 2-year prospective, multi-centre trial. Correlation of retinal fluid and photoreceptor and RPE loss in neovascular AMD by automated quantification, a real-world FRB! analysis. Incidence, risk factors, and patient characteristics in severe contact lens-related microbial keratitis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1